Rare diseases
Investigational molecules
Locations
Back to France658 clinical trials in Grenoble, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Safety and Effects of Berotralstat for Children Aged 2 to 12 with Hereditary Angioedema (HAE)
FranceStudy of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients
FranceFranceFranceLong-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)
FranceStudy on the Safety and Effectiveness of Azacitidine and Venetoclax for Patients with Higher-Risk Chronic Myelomonocytic Leukemia (CMML)
FranceStudy on Personalized Treatment for Metastatic Colorectal Cancer Using Regorafenib for Patients with Advanced Disease
FranceStudy Comparing Chemotherapy and Abemaciclib with Hormone Therapy for Patients with ER+ HER2- Metastatic Breast Cancer with Visceral Involvement
FranceStudy of sildenafil to improve walking distance in patients with peripheral arterial disease and intermittent claudication
FranceStudy on Chlorambucil and Rituximab for Patients with MALT Lymphoma
FranceStudy of Rivaroxaban versus standard care in patients with excessive atrial ectopy or short atrial runs who have high risk of blood clots
FranceStudy on Mepolizumab and Drug Combination for Patients with Eosinophilic Granulomatosis with Polyangiitis
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on head and neck cancers, multiple myeloma, and various types of leukemia. Studies evaluate novel combination therapies and targeted treatments for improved patient outcomes.
Innovative approaches combining immunotherapy with standard treatments are showing promise in treating various forms of cancer.
Clinical investigations examining kidney transplant outcomes and rejection prevention. Research focuses on new therapeutic approaches for managing transplant-related complications.
Studies aim to improve transplant success rates and reduce rejection incidents through innovative medication protocols.
Research into narcolepsy and multiple sclerosis treatments, evaluating new therapeutic approaches for better symptom management and disease control.
Cutting-edge treatments being developed to address both rare and common neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
